Table 4 Summary of cost and outcome results in the base-case analysis
Strategy | Surgery only | Adjuvant S-1 | Adjuvant XELOX |
|---|---|---|---|
Cost of relapse-free state | 445.8 | 14,776.3 | 13,468.3 |
Cost of disease recurrent state | 12,248.6 | 8,984.7 | 6,166.6 |
Cost of death from gastric cancer | 1,174.8 | 1,101.4 | 1,091.7 |
Total cost ($) | 13,638.2 | 24,503.1 | 20,331.6 |
QALYs | 8.1 | 10.8 | 11.5 |
Incremental cost per QALY* | 6,837 | 3,502 |